Article Versions Notes

Chen D-Y, Chen C-C, Tsai M-L, Chang C-Y, Hsieh M-J, Chen T-H, Su P-J, Chu P-H, Hsieh I-C, Pang S-T, et al. Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning. Cancers. 2025; 17(15):2414. https://doi.org/10.3390/cancers17152414

Chen, Dong-Yi, Chun-Chi Chen, Ming-Lung Tsai, Chieh-Yu Chang, Ming-Jer Hsieh, Tien-Hsing Chen, Po-Jung Su, Pao-Hsien Chu, I-Chang Hsieh, See-Tong Pang, and et al. 2025. "Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning" Cancers 17, no. 15: 2414. https://doi.org/10.3390/cancers17152414

Chen, D.-Y., Chen, C.-C., Tsai, M.-L., Chang, C.-Y., Hsieh, M.-J., Chen, T.-H., Su, P.-J., Chu, P.-H., Hsieh, I.-C., Pang, S.-T., & Huang, W.-K. (2025). Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning. Cancers, 17(15), 2414. https://doi.org/10.3390/cancers17152414